← Back to All Filings

Artiva Bio (ARTV) SVP Covers Taxes with $4.5k Stock Sale

Low SignificanceNovember 17, 2025 at 9:02:07 PM EST

Artiva Biotherapeutics, Inc.

$ARTV4CIK: 0001817241

Subscribe to track ARTV

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Artiva Bio (ARTV) SVP Covers Taxes with $4.5k Stock Sale

Company: Artiva Biotherapeutics, Inc. (ARTV) Form: 4 | Filed: 2025-11-17 Significance: Low

Insider: Raymon Heather Title: SVP, Research and Development | Relationship: Officer

Transaction: • Type: Tax Withholding • Shares: 1,375 • Price: $3.25 • Value: $4,469 • Owned After: 39,591

Key Insight: This is a routine, non-discretionary sale to cover tax obligations from vested stock units, not an active market sale by the insider.

Market Context: The transaction value is negligible compared to Artiva's $80 million market capitalization.

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: Artiva Biotherapeutics, Inc. (ARTV)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: An officer at Artiva Biotherapeutics conducted a minor, non-discretionary sale of common stock to cover tax liabilities associated with vested restricted stock units (RSUs).
  • Market Impact: Neutral. This type of transaction is automatic and does not reflect a change in insider sentiment.

Company Information

FieldValue
CompanyArtiva Biotherapeutics, Inc.
Ticker SymbolARTV
CIK0001817241
IndustryBIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

Insider Information

FieldValue
NameRaymon Heather
CIK0002028466
Title/PositionSVP, Research and Development
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-11-15
Transaction CodeF (Withholding of securities for tax liability)
Security TypeCommon Stock
Shares Involved1,375
Price Per Share$3.25
Total Value$4,468.75
Shares Owned After39,591
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$4,468.75
% of Market Cap0.006%
Shares Transacted1,375
% of Shares OutstandingNot Calculable (Data Unavailable)
Post-Transaction Ownership39,591 shares
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The transaction value of approximately $4,500 is insignificant relative to the company's $80 million market capitalization.
  • Transaction Significance: The transaction is classified as low significance. It represents a minuscule fraction of the company's market value and is a common, automated process for handling taxes on equity compensation, not a discretionary trading decision.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction was a sale-to-cover for tax purposes, as indicated by the 'F' transaction code and the filing's footnote. Such events are pre-planned or automatic and do not signal a change in the insider's outlook on the company.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The number of shares is too small to impact trading volume.
  • Sentiment Indicator: Neutral. This filing does not provide any bullish or bearish signals.

Additional Context

Transaction Notes

  • Special Circumstances: The filing footnote explicitly states, "Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of restricted stock unit awards." This confirms the non-discretionary nature of the sale.
Topics:#SECFiling#InsiderTrading#ArtivaBiotherapeutics#ARTV#Form4#TaxWithholding#BiotechStocks#MarketAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.